Cell Signaling Technology, Inc.

United States of America


 
Total IP 183
Total IP Rank # 7,067
IP Activity Score 2.4/5.0    32
IP Activity Rank # 23,970
Dominant Nice Class Chemical and biological material...

Patents

Trademarks

50 29
7 14
56 11
16
 
Last Patent 2023 - Motif-specific and context-indep...
First Patent 2001 - Production of motif-specific and...
Last Trademark 2024 - INTRASEQ
First Trademark 2002 - PHOSPHOSITE

Subsidiaries

1 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Reagent kits comprising reagents, monoclonal antibodies and nucleic acids for scientific or resea...
G/S Reagent kits comprising reagents, monoclonal antibodies and nucleic acids for scientific or rese...
2023 G/S Reagent kits comprising reagents, antibodies and nucleic acids; reagents for scientific and rese...
G/S Reagent kits comprising reagents, antibodies and nucleic acids; reagents for scientific and resea...
2022 Invention Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-c...
G/S Antibodies, enzymes and nucleic acids for scientific and research use in the field of signal tran...
Invention Quick response (qr) code system. A machine-readable code can be provided on a container such as a...
2021 Invention Egfr and ros1 kinase in cancer. The present disclosure provides methods of that include detectin...
Invention Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancer. ...
Invention Ros kinase in lung cancer. The invention provides the identification of the presence of polypept...
2020 G/S Reagents for scientific and clinical research use, namely, kits containing antibodies, proteins, ...
Invention Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer. Novel gene deletions...
Invention Mass spectrometry analysis of mutant polypeptides in biological samples. The invention relates to...
Invention Translocation and mutant ros kinase in human non-small cell lung carcinoma. In accordance with th...
Invention Multi component detection. The disclosure provides methods for detecting the concurrent presence...
2019 Invention Translocation and mutant ros kinase in human non-small cell lung carcinoma. In accordance with t...
Invention Analysis of ubiquitinated polypeptides. The disclosure relates to antibody reagents that specific...
Invention Method for predicting the response to her2-directed therapy. This invention provides methods for...
2018 Invention Apparatus for supporting and carrying container with respect to optical reader. A supporting and ...
Invention Ros kinase in lung cancer. The invention provides the identification of the presence of polypepti...
Invention Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer. Novel gene del...
Invention Methods and reagents for creating monoclonal antibodies. In some embodiments, the invention rela...
2017 Invention Production of motif-specific and context-independent antibodies using peptide libraries as antige...
Invention Methods of treating lung cancer by administration of an alk inhibitor. Novel gene deletions and ...
Invention Alk and ros kinase in cancer. The invention provides a method for identifying a patient with can...
Invention Multi component detection. The disclosure provides methods for detecting the concurrent presence ...
2016 Invention Mutant ros expression in human cancer. The invention provides the identification of the presence...
Invention Methods of treating non-small cell lung carcinoma (nsclc). Novel gene deletions and translocation...
Invention Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase mot...
2015 Invention Methylation and acetylation sites. The disclosure features over 5000 methylation and acetylation ...
Invention Altered antibodies and methods of making the same. This disclosure provides altered (e.g., humani...
Invention Identification of non-small cell lung carcinoma (nsclc) tumors expressing pdgfr-alpha. The inven...
Invention Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancer. T...
G/S Biochemical reagents used for non-medical purposes; Biochemicals, namely, monoclonal antibodies f...
G/S Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; laboratory ...
Invention Method for predicting the response to her2-directed therapy. This invention provides methods for ...
2014 G/S Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Laboratory c...
Invention Analysis of ubiquitnated polypeptides. The disclosure relates to antibody reagents that specific...
Invention Cancer classification and methods of use. The present invention relates to methods of classifyin...
Invention Mutant ros expression in human cancer. The invention provides the identification of the presence ...
Invention Anti-mucin 1 binding agents and uses thereof. This disclosure provides anti-MUC1 binding agents (...
2013 Invention Gene defects and mutant alk kinase in human solid tumors. Novel gene deletions and translocation...
Invention Anti-human cytomegalovirus antibodies and use thereof. This disclosure provides anti-human cytom...
Invention Immunoaffinity isolation of modified peptides from complex mixtures. 3 analysis, or the step of (...
2012 Invention Multi component antibody based detection technology. The disclosure provides methods for detectin...
G/S Antibodies, enzymes and nucleic acids for scientific and research use; diagnostic preparations fo...
G/S Biological research in the field of proteomics and cellular signal transduction; diagnostic servi...
2011 G/S Assays and reagents for use in genetic research; assays for research purposes; biochemical reage...
G/S Assays and reagents for use in genetic research; Assays for research purposes; Biochemical reagen...
G/S Reagents for scientific and clinical research use, namely, kits comprising modification-specific...
G/S Reagents for scientific and clinical research use, namely, kits containing nucleic acids for the...
G/S Biochemical catalysts; biochemical reagents used for non-medical purposes; biochemicals, namely,...
G/S Biochemical research and development; biological research; biomedical research services; chemica...
2010 G/S Biochemical catalysts; Biochemical reagents used for non-medical purposes; Biochemicals, namely, ...
G/S Biochemical research and development; Biological research; Biomedical research services; Chemical...
G/S Biological research; Laboratory research in the field of biotechnology; Scientific and technologi...
G/S Antibodies for the detection of signaling molecules, post-translational modifications on signalin...
G/S Reagents for scientific or medical research use, namely, antibodies for the detection of signalin...
2009 G/S Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein o...
G/S Reagents for research purposes in the pharmaceutical field, the laboratory research field, and th...
G/S Assays and reagents for use in genetic research; Biochemical reagents commonly known as probes, f...
2008 G/S Providing temporary use of an online, non-downloadable database featuring medical and scientific ...
G/S Reagents for scientific and clinical research use, namely, kits containing antibodies and/or nucl...
2006 G/S Reagents for scientific and clinical research use, namely, kits containing nucleic acids, control...
G/S Reagents for scientific and clinical research use. Scientific research and development services i...
2005 G/S Scientific research and development services in the field of life sciences